Oyster Point Pharma, Inc. (OYST)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

202 CARNEGIE CENTER PRINCETON, NJ 08540

Oyster Point Pharma, Inc. operates as a biopharmaceutical company. The Company discovers and develops novel therapies to treat ocular surface diseases. Oyster Point Pharma serves patients in the United States.

Data as of 2021-02-27 11:27:06 -0500
Market Cap513.271 Million Shares Outstanding25.91 Million Avg 30-day Volume103.017 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-5.69 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.91575 52-week High/Low39.21 / 17.24 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from OYST instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 4 -25.0% 1 (0.06%) 1 (0.06%) 0.0%
Funds Holding: 57 66 -13.64% 23 (1.39%) 28 (1.74%) -17.86%
13F shares: 17.566 Million 18.142 Million -3.17% 8.824 Million 8.811 Million 0.14%
% Ownership 67.9074 70.1339 -3.17% 34.1105 34.0612 0.14%
New Positions: 3 7 -57.14% 2 4 -50.0%
Increased Positions 28 21 33.33% 12 8 50.0%
Closed Positions 10 13 -23.08% 7 2 250.0%
Reduced Positions 12 20 -40.0% 4 9 -55.56%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding OYST (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding OYST BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

19.1 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LOCHNER DANIEL CHIEF FINANCIAL OFFICER

  • Officer
219,472 2021-02-24 5

NAU JEFFREY PRESIDENT AND CEO

  • Officer
  • Director
546,672 2021-02-19 3

OZAWA CLARE

  • Director
  • 10% Owner
5,262,254 2021-02-17 2

VERSANT VENTURE CAPITAL VI, L.P.

VERSANT VENTURES VI GP, L.P.

VERSANT VENTURES VI GP-GP, LLC

VERSANT VANTAGE I, L.P.

VERSANT VANTAGE I GP, L.P.

VERSANT VANTAGE I GP-GP, LLC

VERSANT VENTURES IV, LLC

VERSANT VENTURE CAPITAL IV, L.P.

VERSANT SIDE FUND IV, L.P.

  • 10% Owner
5,255,282 2021-02-17 1

SNISARENKO JOHN CHIEF COMMERCIAL OFFICER

  • Officer
18,222 2021-01-29 2

LINK WILLIAM J PHD

  • Director
2,049,278 2020-12-10 2

ATIEH MICHAEL G

  • Director
19,695 2020-10-08 2

ACKERMANN MICHAEL

  • Director
292,729 2020-06-08 1

MURRAY MARK ANTHONY

  • Director
115,047 2020-06-08 1

TSAI BENJAMIN

  • Director
6,600 2020-06-08 1

WEISNER AIMEE S

  • Director
29,725 2020-06-08 1

BEHBAHANI ALI

  • Director
6,600 2020-06-08 1

INVOPPS GP IV, L.L.C.

INVOPPS IV, L.P.

INVOPPS IV US, L.P.

LAINOVIC SACHA

  • Director
  • 10% Owner
2,768,586 2020-05-19 1

OYSTER POINT PHARMA I, LLC

  • 10% Owner
955,392 2019-11-04 0

KLEINER PERKINS CAUFIELD & BYERS XIV, LLC

KPCB XIV ASSOCIATES, LLC

KPCB XIV FOUNDERS FUND, LLC

  • 10% Owner
367,987 2019-11-04 0

VIDA VENTURES, LLC

  • 10% Owner
963,468 2019-11-04 0

KKR FUND HOLDINGS L.P.

KRAVIS HENRY R

ROBERTS GEORGE R

KKR MANAGEMENT LLC

KKR & CO. INC.

KKR GROUP HOLDINGS CORP.

KKR FUND HOLDINGS GP LTD

1,039,622 2019-11-04 0

FALCON VISION LLC

KKR HEALTHCARE STRATEGIC GROWTH FUND L.P.

KKR HCSG GP LLC

KKR ASSOCIATES HCSG L.P.

1,039,622 2019-11-04 0

NEW ENTERPRISE ASSOCIATES 14, L.P.

SONSINI PETER W.

BARRIS PETER J

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

BASKETT FOREST

FLORENCE ANTHONY A. JR.

MOTT DAVID M

SANDELL SCOTT D

  • 10% Owner
5,925,287 2019-11-04 0

NEW ENTERPRISE ASSOCIATES 14, L.P.

SONSINI PETER W.

NEA PARTNERS 14, L.P.

NEA 14 GP, LTD

BASKETT FOREST

FLORENCE ANTHONY A. JR.

MOTT DAVID M

SANDELL SCOTT D

  • 10% Owner
322,458 2019-10-30 0

BARRIS PETER J

  • 10% Owner
322,458 2019-10-30 0

KERINS PATRICK J

  • 10% Owner
5,925,287 2019-10-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

LOCHNER DANIEL - Officer CHIEF FINANCIAL OFFICER

2021-02-26 19:50:12 -0500 2021-02-24 M 9,109 d 184,841 direct

LOCHNER DANIEL - Officer CHIEF FINANCIAL OFFICER

2021-02-26 19:50:12 -0500 2021-02-24 M 9,109 $11.51 a 34,631 direct

NAU JEFFREY - Director - Officer PRESIDENT AND CEO

2021-02-23 20:13:49 -0500 2021-02-19 M 10,000 $1.02 a 40,898 direct

NAU JEFFREY - Director - Officer PRESIDENT AND CEO

2021-02-23 20:13:49 -0500 2021-02-19 M 10,000 d 504,774 direct

VERSANT VENTURE CAPITAL VI, L.P. - > 10% Owner see footnotes

VERSANT VENTURES VI GP, L.P. - > 10% Owner see footnotes

VERSANT VENTURES VI GP-GP, LLC - > 10% Owner see footnotes

VERSANT VANTAGE I, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP-GP, LLC - > 10% Owner see footnotes

VERSANT VENTURES IV, LLC - > 10% Owner see footnotes

VERSANT VENTURE CAPITAL IV, L.P. - > 10% Owner see footnotes

VERSANT SIDE FUND IV, L.P. - > 10% Owner see footnotes

2021-02-19 17:16:45 -0500 2021-02-17 J 6,500 d 0 indirect

OZAWA CLARE - Director - > 10% Owner

2021-02-19 17:13:00 -0500 2021-02-17 J 372 a 6,972 direct

OZAWA CLARE - Director - > 10% Owner see footnotes

2021-02-19 17:13:00 -0500 2021-02-17 J 6,500 d 0 indirect

VERSANT VENTURE CAPITAL VI, L.P. - > 10% Owner see footnotes

VERSANT VENTURES VI GP, L.P. - > 10% Owner see footnotes

VERSANT VENTURES VI GP-GP, LLC - > 10% Owner see footnotes

VERSANT VANTAGE I, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP-GP, LLC - > 10% Owner see footnotes

VERSANT VENTURES IV, LLC - > 10% Owner see footnotes

VERSANT VENTURE CAPITAL IV, L.P. - > 10% Owner see footnotes

VERSANT SIDE FUND IV, L.P. - > 10% Owner see footnotes

2021-02-19 17:16:45 -0500 2021-02-17 J 5,607 d 0 indirect

VERSANT VENTURE CAPITAL VI, L.P. - > 10% Owner see footnotes

VERSANT VENTURES VI GP, L.P. - > 10% Owner see footnotes

VERSANT VENTURES VI GP-GP, LLC - > 10% Owner see footnotes

VERSANT VANTAGE I, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP-GP, LLC - > 10% Owner see footnotes

VERSANT VENTURES IV, LLC - > 10% Owner see footnotes

VERSANT VENTURE CAPITAL IV, L.P. - > 10% Owner see footnotes

VERSANT SIDE FUND IV, L.P. - > 10% Owner see footnotes

2021-02-19 17:16:45 -0500 2021-02-17 J 6,500 a 6,500 indirect

OZAWA CLARE - Director - > 10% Owner see footnotes

2021-02-19 17:13:00 -0500 2021-02-17 J 5,607 d 0 indirect

OZAWA CLARE - Director - > 10% Owner see footnotes

2021-02-19 17:13:00 -0500 2021-02-17 J 6,500 a 6,500 indirect

VERSANT VENTURE CAPITAL VI, L.P. - > 10% Owner see footnotes

VERSANT VENTURES VI GP, L.P. - > 10% Owner see footnotes

VERSANT VENTURES VI GP-GP, LLC - > 10% Owner see footnotes

VERSANT VANTAGE I, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP, L.P. - > 10% Owner see footnotes

VERSANT VANTAGE I GP-GP, LLC - > 10% Owner see footnotes

VERSANT VENTURES IV, LLC - > 10% Owner see footnotes

VERSANT VENTURE CAPITAL IV, L.P. - > 10% Owner see footnotes

VERSANT SIDE FUND IV, L.P. - > 10% Owner see footnotes

2021-02-19 17:16:45 -0500 2021-02-17 J 5,607 a 5,607 indirect

VERSANT VENTURE CAPITAL VI, L.P. - > 10% Owner

VERSANT VENTURES VI GP, L.P. - > 10% Owner

VERSANT VENTURES VI GP-GP, LLC - > 10% Owner

VERSANT VANTAGE I, L.P. - > 10% Owner

VERSANT VANTAGE I GP, L.P. - > 10% Owner

VERSANT VANTAGE I GP-GP, LLC - > 10% Owner

VERSANT VENTURES IV, LLC - > 10% Owner

VERSANT VENTURE CAPITAL IV, L.P. - > 10% Owner

VERSANT SIDE FUND IV, L.P. - > 10% Owner

2021-02-19 17:16:45 -0500 2021-02-17 J 325,000 d 2,236,888 direct yes

OZAWA CLARE - Director - > 10% Owner see footnotes

2021-02-19 17:13:00 -0500 2021-02-17 J 5,607 a 5,607 indirect

OZAWA CLARE - Director - > 10% Owner see footnotes

2021-02-19 17:13:00 -0500 2021-02-17 J 325,000 d 2,236,888 indirect yes

LOCHNER DANIEL - Officer CHIEF FINANCIAL OFFICER

2021-02-02 18:32:19 -0500 2021-01-29 A 11,222 a 25,522 direct

SNISARENKO JOHN - Officer CHIEF COMMERCIAL OFFICER

2021-02-02 18:35:20 -0500 2021-01-29 A 50,500 a 50,500 direct

NAU JEFFREY - Director - Officer PRESIDENT AND CEO

2021-02-02 18:33:37 -0500 2021-01-29 A 25,898 a 30,898 direct

SNISARENKO JOHN - Officer CHIEF COMMERCIAL OFFICER

2021-02-02 18:35:20 -0500 2021-01-29 A 11,222 a 18,222 direct

LOCHNER DANIEL - Officer CHIEF FINANCIAL OFFICER

2021-02-02 18:32:19 -0500 2021-01-29 A 50,500 d 50,500 direct

NAU JEFFREY - Director - Officer PRESIDENT AND CEO

2021-02-02 18:33:37 -0500 2021-01-29 A 116,539 a 116,539 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
OYSTER POINT PHARMA INC OYST 2021-02-26 22:15:02 UTC -0.5693 0.6393 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 21:45:03 UTC -0.5693 0.6393 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 21:15:02 UTC -0.5693 0.6393 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 20:45:03 UTC -0.5693 0.6393 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 20:15:03 UTC -0.5693 0.6393 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 19:45:03 UTC -0.5693 0.6393 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 19:15:03 UTC -0.5693 0.6393 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 18:45:03 UTC -0.5694 0.6394 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 18:15:02 UTC -0.5694 0.6394 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 17:45:02 UTC -0.5694 0.6394 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 17:15:03 UTC -0.5694 0.6394 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 16:45:03 UTC -0.5694 0.6394 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 16:15:02 UTC -0.5694 0.6394 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 15:45:03 UTC -0.5694 0.6394 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 15:15:03 UTC -0.5694 0.6394 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 14:45:03 UTC -0.5506 0.6206 60000
OYSTER POINT PHARMA INC OYST 2021-02-26 13:00:03 UTC -0.5506 0.6206 60000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments